Answers are grounded in this paper and cite their sources.
We report on a 57-year-old woman, diagnosed with Parkinson's disease, whose panic disorder showed marked improvement after introduction of bupropion, a norepinephrine-dopamine reuptake inhibitor. Additionally a comorbid major depression disappeared under this treatment. Bupropion may be useful for the treatment of patients with both panic disorder and Parkinson's disease.
No takes yet. Share an insight, caveat, or question.
Gebhardt et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: